Brian V. Balgobind

2.4k total citations
45 papers, 807 citations indexed

About

Brian V. Balgobind is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Hematology. According to data from OpenAlex, Brian V. Balgobind has authored 45 papers receiving a total of 807 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pulmonary and Respiratory Medicine, 14 papers in Radiation and 14 papers in Hematology. Recurrent topics in Brian V. Balgobind's work include Acute Myeloid Leukemia Research (14 papers), Advanced Radiotherapy Techniques (14 papers) and Radiation Therapy and Dosimetry (13 papers). Brian V. Balgobind is often cited by papers focused on Acute Myeloid Leukemia Research (14 papers), Advanced Radiotherapy Techniques (14 papers) and Radiation Therapy and Dosimetry (13 papers). Brian V. Balgobind collaborates with scholars based in Netherlands, Germany and France. Brian V. Balgobind's co-authors include Marry M. van den Heuvel‐Eibrink, C. Michel Zwaan, Rob Pieters, Dirk Reinhardt, Gertjan J.L. Kaspers, Iris H.I.M. Hollink, H. Berna Beverloo, Ursula Creutzig, Elisabeth R. van Wering and Susan T.C.J.M. Arentsen-Peters and has published in prestigious journals such as Blood, European Journal of Cancer and Physics in Medicine and Biology.

In The Last Decade

Brian V. Balgobind

44 papers receiving 796 citations

Peers

Countries citing papers authored by Brian V. Balgobind

Since Specialization

Citations

This map shows the geographic impact of Brian V. Balgobind's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian V. Balgobind with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian V. Balgobind more than expected).

Fields of papers citing papers by Brian V. Balgobind

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian V. Balgobind. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian V. Balgobind. The network helps show where Brian V. Balgobind may publish in the future.

Co-authorship network of co-authors of Brian V. Balgobind

This figure shows the co-authorship network connecting the top 25 collaborators of Brian V. Balgobind. A scholar is included among the top collaborators of Brian V. Balgobind based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian V. Balgobind. Brian V. Balgobind is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Long-Term Outcomes After Multidisciplinary Treatment for Pediatric Orbital Rhabdomyosarcoma 2025 ·Cancers ·(unknown), Johannes H. M. Merks, (unknown), Brian V. Balgobind, C. Dilara Savci‐Heijink, (unknown), Bradley R. Pieters, Peerooz Saeed	1
2	Auto-contouring of cardiac substructures for Stereotactic arrhythmia radioablation (STAR): A STOPSTORM.eu consortium study 2024 ·Radiotherapy and Oncology ·(unknown), Oliver Blanck, (unknown), (unknown), Lukáš Knybel, Brian V. Balgobind, Joost J.C. Verhoeff, Marcin Miszczyk, Sławomir Blamek, (unknown), Nicolaus Andratschke, Felix Mehrhof, Judit Boda‐Heggemann, Bartłomiej Tomasik, Stefano Mandija, Martin F. Fast	2
3	Timing matters: diurnal spine length variation in pediatric patients during radiotherapy 2024 ·Radiation Oncology ·(unknown), Irma W.E.M. van Dijk, (unknown), Brian V. Balgobind, (unknown), N. Van Wieringen, Arjan Bel	0
4	Non-invasive stereotactic arrhythmia radiotherapy for ventricular tachycardia: results of the prospective STARNL-1 trial 2023 ·EP Europace ·Martijn H. van der Ree, Edith Dieleman, J. Visser, R. Nils Planken, S. Matthijs Boekholdt, (unknown), C. Rasch, (unknown), (unknown), Michiel J. B. Kemme, Jippe C. Balt, Arthur A.M. Wilde, Brian V. Balgobind, Pieter G. Postema	23
5	Direct Clinical Effects of Cardiac Radioablation in the Treatment of a Patient With Therapy-Refractory Ventricular Tachycardia Storm 2022 ·Advances in Radiation Oncology ·Martijn H. van der Ree, Edith Dieleman, J. Visser, Judit A. Adam, (unknown), (unknown), (unknown), Arend Mosterd, Jippe C. Balt, R. Nils Planken, Brian V. Balgobind, Pieter G. Postema	6
6	Standardizing the Cardiac Radioablation Targeting Workflow: Enabling Semi-Automated Angulation and Segmentation of the Heart According to the American Heart Association Segmented Model 2022 ·Advances in Radiation Oncology ·Martijn H. van der Ree, J. Visser, R. Nils Planken, Edith Dieleman, S. Matthijs Boekholdt, Brian V. Balgobind, Pieter G. Postema	18
7	Patterns of Hearing Loss in Irradiated Survivors of Head and Neck Rhabdomyosarcoma 2022 ·Cancers ·(unknown), (unknown), Reineke A. Schoot, Rutger R. G. Knops, Charlotte L. Zuur, (unknown), Raquel Dávila Fajardo, Bradley R. Pieters, Brian V. Balgobind, Henrike Westerveld, Nicole Freling, Harm van Tinteren, Ludwig E. Smeele, Arjan Bel, Marry M. van den Heuvel‐Eibrink, Robert J. Stokroos, Johannes H. M. Merks, (unknown), M. Hol	3
8	Pediatric radiotherapy for thoracic and abdominal targets: Organ motion, reported margin sizes, and delineation variations – A systematic review 2022 ·Radiotherapy and Oncology ·(unknown), Irma W.E.M. van Dijk, (unknown), Joost G. Daams, Brian V. Balgobind, Arjan Bel	5
9	Cardiac radioablation—A systematic review 2020 ·Heart Rhythm ·Martijn H. van der Ree, Oliver Blanck, Jacqueline Limpens, (unknown), Brian V. Balgobind, Edith Dieleman, Arthur A.M. Wilde, Paul C. Zei, Joris R. de Groot, Ben J. Slotman, Phillip S. Cuculich, Clifford G. Robinson, Pieter G. Postema	85
10	Surrogate-free machine learning-based organ dose reconstruction for pediatric abdominal radiotherapy 2020 ·Physics in Medicine and Biology ·Marco Virgolin, Ziyuan Wang, Brian V. Balgobind, Irma W.E.M. van Dijk, J. Wiersma, P.S. Kroon, Geert O. Janssens, Marcel van Herk, David Hodgson, Lorna Zadravec Zaletel, C. Rasch, Arjan Bel, Peter A. N. Bosman, Tanja Alderliesten	2
11	EP-1991 PTV margin evaluation for pediatric craniospinal irradiation with 3D and 2D position verification 2019 ·Radiotherapy and Oncology ·E. A. van Slooten, N. Van Wieringen, (unknown), Brian V. Balgobind, (unknown), (unknown), (unknown), Arjan Bel	1
12	How do patient characteristics and anatomical features correlate to accuracy of organ dose reconstruction for Wilms’ tumor radiation treatment plans when using a surrogate patient’s CT scan? 2019 ·Journal of Radiological Protection ·Ziyuan Wang, Brian V. Balgobind, Marco Virgolin, Irma W.E.M. van Dijk, (unknown), Cécile M. Ronckers, Peter A. N. Bosman, Arjan Bel, Tanja Alderliesten	4
13	Predictive value of pediatric respiratory-induced diaphragm motion quantified using pre-treatment 4DCT and CBCTs 2018 ·Radiation Oncology ·(unknown), Irma W.E.M. van Dijk, J. Visser, Brian V. Balgobind, C. Rasch, Tanja Alderliesten, Arjan Bel	6
14	Heart volume reduction during radiotherapy involving the thoracic region in children: An unexplained phenomenon 2018 ·Radiotherapy and Oncology ·Irma W.E.M. van Dijk, J. Visser, (unknown), (unknown), Brian V. Balgobind, Elizabeth A. M. Feijen, (unknown), Wouter E.M. Kok, Leontien C.M. Kremer, C. Rasch, Arjan Bel	1
15	A review of the clinical experience in pulsed dose rate brachytherapy 2015 ·British Journal of Radiology ·Brian V. Balgobind, Kees Koedooder, (unknown), Raquel Dávila Fajardo, C. Rasch, Bradley R. Pieters	15
16	Integrative analysis of type-I and type-II aberrations underscores the genetic heterogeneity of pediatric acute myeloid leukemia 2011 ·Haematologica ·Brian V. Balgobind, Iris H.I.M. Hollink, Susan T.C.J.M. Arentsen-Peters, M Zimmermann, Jochen Harbott, H. Berna Beverloo, Anne R. M. von Bergh, Jacqueline Cloos, Gertjan J.L. Kaspers, Válerie de Haas, Zuzana Zemanová, Jan Starý, J M Cayuela, André Baruchel, Ursula Creutzig, Dirk Reinhardt, R. Pieters, C. Michel Zwaan, Marry M. van den Heuvel‐Eibrink	76
17	Low frequency of MLL-partial tandem duplications in paediatric acute myeloid leukaemia using MLPA as a novel DNA screenings technique 2010 ·European Journal of Cancer ·Brian V. Balgobind, Iris H.I.M. Hollink, Dirk Reinhardt, Elisabeth R. van Wering, Siebold S.N. de Graaf, André Baruchel, Jan Starý, H. Berna Beverloo, Georgine E. de Greef, Rob Pieters, C. Michel Zwaan, Marry M. van den Heuvel‐Eibrink	16
18	EVI1 overexpression in distinct subtypes of pediatric acute myeloid leukemia 2010 ·Leukemia ·Brian V. Balgobind, Sanne Lugthart, Iris H.I.M. Hollink, (unknown), Elisabeth R. van Wering, Siebold S.N. de Graaf, Dirk Reinhardt, Ursula Creutzig, Gertjan J.L. Kaspers, Eveline S.J.M. de Bont, Jan Starý, Jan Trka, M Zimmermann, H. Berna Beverloo, Rob Pieters, Ruud Delwel, C. Michel Zwaan, Marry M. van den Heuvel‐Eibrink	57
19	Characterization of CEBPA mutations and promoter hypermethylation in pediatric acute myeloid leukemia 2010 ·Haematologica ·Iris H.I.M. Hollink, Marry M. van den Heuvel‐Eibrink, Susan T.C.J.M. Arentsen-Peters, Martin Zimmermann, (unknown), Peter J.M. Valk, Brian V. Balgobind, Edwin Sonneveld, Gertjan J.L. Kaspers, Eveline S.J.M. de Bont, Jan Trka, André Baruchel, Ursula Creutzig, R. Pieters, Dirk Reinhardt, C. Michel Zwaan	48
20	Clinical relevance of Wilms tumor 1 gene mutations in childhood acute myeloid leukemia 2009 ·Blood ·Iris H.I.M. Hollink, Marry M. van den Heuvel‐Eibrink, Martin Zimmermann, Brian V. Balgobind, Susan T.C.J.M. Arentsen-Peters, Mariëlle Alders, André Willasch, Gertjan J.L. Kaspers, Jan Trka, André Baruchel, Siebold S.N. de Graaf, Ursula Creutzig, Rob Pieters, Dirk Reinhardt, C. Michel Zwaan	80

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact